The evidence accumulated in recent years indicates that METTL14 inhibits the malignant progression of various cancer cells, such as colorectal cancer [32, 33], liver cancer [34, 35] and renal cell carcinoma [36, 37]. This evidence concerns the gene METTL14 and hereditary clear cell renal cell carcinoma.